Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

Author(s):
Taylor, P.C.; Keystone, E.C.; Heijde, D. van der; Tanaka, Y.; Ishii, T.; Emoto, K.; Yang, L.L.; Arora, V.; Gaich, C.L.; Rooney, T.; Schlichting, D.E.; Macias, W.; Bono, S. de; Weinblatt, M.E.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-10-31
Language
English
Is part of
Arthritis and Rheumatology
hdl
1887/114313